Dysfunction of Natural Killer T Cells in Patients with Active Mycobacterium tuberculosis Infection

Rapid NKT Cell Responses Are Self-Terminating during the Course of Microbial Infection

(2014) A. Chiba et al.   JOURNAL OF IMMUNOLOGY

Cutting Edge: Programmed Death-1/Programmed Death Ligand 1 Interaction Regulates the Induction and Maintenance of Invariant NKT Cell Anergy

(2014) W.-S. Chang et al.   JOURNAL OF IMMUNOLOGY

Numerical and functional deficiencies of natural killer T cells in systemic lupus erythematosus: their deficiency related to disease activity

(2011) Y.-N. Cho et al.   RHEUMATOLOGY

α-Galactosylceramide as a Therapeutic Agent for PulmonaryMycobacterium tuberculosisInfection

(2010) Isabel Sada-Ovalle et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Profound invariant natural killer T-cell deficiency in inflammatory arthritis

(2010) S. J. Tudhope et al.   ANNALS OF THE RHEUMATIC DISEASES

Invariant NKT cells limit activation of autoreactive CD1d-positive B cells

(2010) Fredrik Wermeling et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Evaluation of Cell Surface Expression of Phosphatidylserine in Ovarian Carcinoma Effusions Using the Annexin-V/7-AAD Assay

(2009) Hiep Phuc Dong et al.   AMERICAN JOURNAL OF CLINICAL PATHOLOGY

Impaired differentiation and cytotoxicity of natural killer cells in systemic lupus erythematosus

(2009) Yong-Wook Park et al.   ARTHRITIS AND RHEUMATISM

Severe functional impairment and elevated PD-1 expression in CD1d-restricted NKT cells retained during chronic HIV-1 infection

(2009) Markus Moll et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Incorporation of NKT Cell-Activating Glycolipids Enhances Immunogenicity and Vaccine Efficacy of Mycobacterium bovis Bacillus Calmette-Guerin

(2009) M. M. Venkataswamy et al.   JOURNAL OF IMMUNOLOGY

PD-1/PD-L Blockade Prevents Anergy Induction and Enhances the Anti-Tumor Activities of Glycolipid-Activated Invariant NKT Cells

(2009) V. V. Parekh et al.   JOURNAL OF IMMUNOLOGY

High granulocyte/lymphocyte ratio and paucity of NKT cells defines TB disease in a TB-endemic setting

(2009) Jayne S. Sutherland et al.   TUBERCULOSIS

PD-1 and Its Ligands in Tolerance and Immunity

(2008) Mary E. Keir et al.   Annual Review of Immunology

Invariant NKT cells from HIV-1 or Mycobacterium tuberculosis-infected patients express an activated phenotype

(2008) Carlos J. Montoya et al.   CLINICAL IMMUNOLOGY

Insufficient ex vivo expansion of Vα24+ natural killer T cells in malignant lymphoma patients related to the suppressed expression of CD1d molecules on CD14+ cells

(2008) O. Imataki et al.   CYTOTHERAPY

Selective activation, expansion, and monitoring of human iNKT cells with a monoclonal antibody specific for the TCR α-chain CDR3 loop

(2008) Mark A. Exley et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Bacterial infection alters the kinetics and function of iNKT cell responses

(2008) Hak-Jong Choi et al.   JOURNAL OF LEUKOCYTE BIOLOGY

Innate Invariant NKT Cells Recognize Mycobacterium tuberculosis–Infected Macrophages, Produce Interferon-γ, and Kill Intracellular Bacteria

(2008) Isabel Sada-Ovalle et al.   PLoS Pathogens